Similar documents
/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

ACUTE CENTRAL PERIFERALEMBOLISM

Stroke/TIA. Tom Bedwell

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS

Management and Investigation of Ischemic Stroke By Etiology

How to Evaluate Patients with Cryptogenic Stroke

Permanent foramen ovale: when to close?

PFO Management update

MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist. neurointerventionist

Acute stroke. Ischaemic stroke. Characteristics. Temporal classification. Clinical features. Interpretation of Emergency Head CT

What the general cardiologist should know about arrhythmia Stroke prevention in AF" Peter Ammann Kantonsspital St. Gallen

How Can We Properly Manage Patients With Stroke of Undetermined Origin?

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014

Ischemic Stroke in Critically Ill Patients with Malignancy

Acute arterial embolism

Cryptogenic Strokes: Evaluation and Management

11/2/2016. Stroke. Carl F. McComas, M.D. November 3, Disclosures. None (of any kind)

Is Stroke a Paradoxical Embolism in Patients with Patent Foramen Ovale?

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute

Intended Learning Outcomes

Cerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11

Cryptogenic Stroke: A logical approach to a common clinical problem

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville

2017 Cardiovascular Symposium CRYPTOGENIC STROKE: A CARDIOVASCULAR PERSPECTIVE DR. WILLIAM DIXON AND DR. VENKATA BAVAKATI SOUTHERN MEDICAL GROUP, P.A.

TIA: Updates and Management 2008

Cerebral Vascular Diseases. Nabila Hamdi MD, PhD

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate?

MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL The following is a list of variables and how to complete each one:

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

CT and MR Imaging in Young Stroke Patients

Key Clinical Concepts

Cryptogenic Stroke: What Don t We Know. Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare

CEREBRO VASCULAR ACCIDENTS

The Impact of Smoking on Acute Ischemic Stroke

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

Sixth Annual Intensive Update in Neurology 9/15-16/2016. W Tom Kushner DO Swedish Stroke Clinic Neurohospitalist

Cerebrovascular Disease. RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Essentials of Clinical MR, 2 nd edition. 14. Ischemia and Infarction II

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance

Stroke Topics. Advances in the Prevention and Treatment of Stroke. Non-Contrast Head CT. Patient 1-68 yo man

PFO- To Close for Comfort. By: Vincent J.Caracciolo, MD FACC

Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance

Stroke School for Internists Part 1

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

EAE RECOMMENDATIONS FOR TRANSESOPHAGEAL ECHO. Cardiac Sources of Embolism. Luigi P. Badano, MD, FESC

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018

Stroke Case Studies. Dr Stuti Joshi Neurology Advanced Trainee Telestroke fellow

GERIATRICS CASE PRESENTATION

Dr Ben Turner. Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease

III./ Cerebral embolism

Process Measure: Screening for Adult Obstructive Sleep Apnea

2018 Update in Diagnosis and Management of Stroke

Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship

CMS Limitations Guide - Radiology Services

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia

CAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough

Brain Attack. Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship. Case Medical Center

NON-ATHEROSCLEROTIC PATHOLOGY OF THE CAROTID ARTERIES

Blood Supply. Allen Chung, class of 2013

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United

Raluca Pavaloiu et al. - Clinical, Epidemiological and Etiopathogenic Study of Ischemic Stroke

2015 Update in Diagnosis and Management of Stroke

CVA. Alison Atwater PA-C

Speakers. 2015, American Heart Association 1

Brain Attacks and Acute Stroke Management

Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece

True cryptogenic stroke

The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging

Ischemic stroke: management, prevention and follow up. Amit Kansara MD Providence Stroke Center Providence Brain and Spine Institute

Carotid Embolectomy and Endarterectomy for Symptomatic Complete Occlusion of the Carotid Artery as a Rescue Therapy in Acute Ischemic Stroke

Nicolas Bianchi M.D. May 15th, 2012

Qualifying and Outcome Strokes in the RESPECT PFO Trial: Additional Evidence of Treatment Effect

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine

Why Should We Treat PFO?

Modena, 6 novembre Heart and Brain. Paolo Bovi

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%

Secondary Stroke Prevention: A Precautionary Tale

An Introduc+on to Stroke

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis

The Importance of Middle Cerebral Artery Stenosis In Patients With A Lacunar Infarction In The Carotid Artery Territory

Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

UvA-DARE (Digital Academic Repository) Cerebral autoregulation: from minutes to seconds Immink, R.V. Link to publication

Karl Meisel, MD MA Director of Stroke Clinic University of California San Francisco

Imaging of the 3 Ps in Stroke An introduction of stroke diagnostics for the non-neurologist

Echocardiography as a diagnostic and management tool in medical emergencies

Subtyping of Ischemic Stroke Based on Vascular Imaging: Analysis of 1,167 Acute, Consecutive Patients

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO

Current Clinical Trials for Stroke Survivors in NJ and Philadelphia Areas

7. Echocardiography Appropriate Use Criteria (by Indication)

Cryptogenic Stroke: The role of silent Atrial Fibrillation

DISCLOSURE TEST YOUR WAVEFORM IQ. Partial volume artifact. 86 yo female with right arm swelling, picc line. AVF on left? Dx?

Pathology of pulmonary vascular disease. Dr.Ashraf Abdelfatah Deyab. Assistant Professor of Pathology Faculty of Medicine Almajma ah University

Alan Barber. Professor of Clinical Neurology University of Auckland

Transcription:

CLINICAL FEATURES THAT SUPPORT ATHEROSCLEROTIC STROKE 1. cerebral cortical impairment (aphasia, neglect, restricted motor involvement, etc.) or brain stem or cerebellar dysfunction 2. lacunar clinical presentation (e.g., pure motor hemiparesis or ataxic hemiparesis) is frequent in ATS stroke 3. TIAs in the same vascular territory, a carotid bruit, diminished pulses support a clinical diagnosis of ATS stroke 4. hypertension, chronic obstructive pulmonary disease, diabetes mellitus, hyperlipidemia are significantly associated with ATS stroke 5. sudden onset of neurological deficit are less frequent in ATS infarctions CLINICAL FEATURES THAT SUPPORT CARDIOEMBOLIC STROKE 1. clinical findings are similar to those described for large-artery atherosclerosis (but, more often: severe stroke, disability and death) 2. cardiac embolism is a very rare cause of lacunar infarction 3. previous TIA or stroke in more than one vascular territory or systemic embolism supports a clinical diagnosis of CE stroke 4. atrial fibrillation, recognition of an emboligenic heart disease are independently associated with CE stroke 5. sudden onset of neurological deficit and the rapid regression of symptoms are important for a clinical suspicion of the CE origin of stroke 6. altered consciousness is a predictive factor of CE cerebral infarction 7. no paradoxical embolism in ATS stroke 7. the onset of symptoms after a Valsalvaprovoking activity (coughing, bending, etc.) suggesting paradoxical embolism.

BIOMARKERS IN CARDIOEMBOLIC/ATHEROSCLEROTIC STROKE 1. at present there is no biologic marker offering precise information about stroke etiology 2. elevated plasma BNP/D-dimer levels can be a potential marker of the presence of left atrial sources of emboli in ischemic stroke pts. 3. BNP/D-dimer are strongly associated with CE stroke and functional outcome 4. the cut-off values of BNP/D-dimer need further validation

CT/MR FINDINGS THAT SUPPORT LA ATS STROKE INCLUDE: cortical or cerebellar lesions and brain stem or subcortical hemispheric infarcts > than 1.5 cm in diameter CT/MR FINDINGS THAT SUPPORT CE STROKE INCLUDE: brain imaging findings are similar to those described for large-artery atherosclerosis unique (more often) ischemic area simultaneous or sequential infarctions in differential arterial territories hemorrhagic transformation of infarction (more frequent in CE stroke)

ECG, TEE, TTE, TCD BUBBLE TEST FINDINGS THAT SUPPORT LA ATS STROKE INCLUDE: no CE sources of high and medium risk (no recognition of an emboligenic heart disease) ECG, TEE, TTE, TCD BUBBLE TEST FINDINGS THAT SUPPORT CE STROKE INCLUDE: ECG, 24-hour Holter ECG, 7-day ECG (AF and PAF diagnosis) TTE/TEE recognition of CE sources of high and medium risk TCD/TEE recognition of rt->lt large shunt in patient with cerebral infarction of unknown aetiology TEE recognition of plaque thickness 4 mm and mobile components in the aortic arch (pts in whom a cerebral infarctionattributable aetiology is not found)

?

?

US/NR FINDINGS THAT SUPPORT LA ATS STROKE INCLUDE: hemodynamic plaque in an intra/extracranial artery supplying the ischemic stroke occlusion with imaging evidence of atherosclerosis in an intra/extracranial artery supplying the ischemic stroke not hemodynamic plaque in an intra/extracranial artery supplying the ischemic field with attached luminal thrombus uniteral MES: suggestive of ATS stroke (TCD monitoring) US/NR FINDINGS THAT SUPPORT CE STROKE INCLUDE: occlusion of the carotid artery by mobile embolus early recanalisation of occluded extra/intracranial vessel simultaneous or sequential embolism in different arteries (extra/intracranial) bilateral MES: suggestive of CE stroke (TCD monitoring)

CARDIOEMBOLIC OR ATHEROSCLEROTIC STROKE? 1. medical history and physical exam; 2. extra-intracranial vessels imaging; 3. head CT±MRI; 4. ECG; 5. chest Rx

CARDIOEMBOLIC OR ATHEROSCLEROTIC STROKE? 1. medical history and physical exam; 2. extra-intracranial vessels imaging; 3. head CT±MRI; 4. ECG; 5. chest Rx DIAGNOSIS 1. CE stroke?; 2. ATS stroke? (with exclusion of other cause for the stroke)

CARDIOEMBOLIC OR ATHEROSCLEROTIC STROKE? 1. medical history and physical exam; 2. extra-intracranial vessels imaging; 3. head CT±MRI; 4. ECG; 5. chest Rx DIAGNOSIS 1. CE stroke?; 2. ATS stroke? (with exclusion of other cause for the stroke) 1. TTE 2. Holter ECG (24 h/7 days) cardiac source of embolism identified CARDIOEMBOLIC STROKE

CARDIOEMBOLIC OR ATHEROSCLEROTIC STROKE? 1. medical history and physical exam; 2. extra-intracranial vessels imaging; 3. head CT±MRI; 4. ECG; 5. chest Rx 1. TTE 2. Holter ECG (24 h/7 days) no cardiac source of embolism identified 1. TEE/TCD bubble test 2. TCD monitoring (bilateral MES) 3. vein ECD/angioCT (IVC, iliac veins) 4. biomarkers (?) cardiac source of embolism identified CARDIOEMBOLIC STROKE DIAGNOSIS 1. CE stroke?; 2. ATS stroke? (with exclusion of other cause for the stroke)

CARDIOEMBOLIC OR ATHEROSCLEROTIC STROKE? 1. medical history and physical exam; 2. extra-intracranial vessels imaging; 3. head CT±MRI; 4. ECG; 5. chest Rx 1. TTE 2. Holter ECG (24 h/7 days) no cardiac source of embolism identified DIAGNOSIS 1. CE stroke?; 2. ATS stroke? (with exclusion of other cause for the stroke) 1. TEE/TCD bubble test 2. TCD monitoring (bilateral MES) 3. vein ECD/angioCT (IVC, iliac veins) 4. biomarkers (?) no cardiac source of embolism identified ATS STROKE

short videos and playlists on echocolor Doppler of the extraintracranial vessels are available on my youtube channel: http://www.youtube.com/channel/ucij561sx0bqoejxiwkupnkg